Metagenomi (MGX) Institutional Ownership

During the previous two years, 54 institutional investors and hedge funds held shares of Metagenomi. The most heavily invested institutionals were Farallon Capital Management LLC ($14.17M), Novo Holdings A S ($7.34M), Artal Group S.A. ($3.17M), RA Capital Management L.P. ($2.83M), PFM Health Sciences LP ($2.24M), Geode Capital Management LLC ($2.12M), and Vanguard Group Inc. ($1.89M).Learn more on MGX's institutional investors.

Of the 43 institutional investors that purchased Metagenomi stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($1.74M), Farallon Capital Management LLC ($1.34M), Hhlr Advisors LTD. ($777.77K), Geode Capital Management LLC ($423.19K), Norges Bank ($360.20K), Peapod Lane Capital LLC ($351.21K), and Artal Group S.A. ($300K).

Institutional investors have bought a total of 7,231,415 shares in the last 24 months. This purchase volume represents approximately $56.34M in transactions.

Of the 17 institutional investors that sold Metagenomi stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Citadel Advisors LLC ($654.76K), Hhlr Advisors LTD. ($627.07K), Millennium Management LLC ($403.47K), Point72 Asset Management L.P. ($272.10K), PFM Health Sciences LP ($233K), RA Capital Management L.P. ($172.51K), and Marshall Wace LLP ($135.11K).

Institutional investors have sold a total of 2,873,592 shares in the last 24 months. This volume of shares sold represents approximately $8.19M in transactions.